Treatment optimization for multiple myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in in vitro and ex vivo models.

ABSTRACT:

SUBMITTER: Borsi E 

PROVIDER: S-EPMC6269297 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature